• / Free eNewsletters & Magazine
  • / My Account
Home>G-7

G-7

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Japanese yen soars to fresh 18-month high against the dollar

    Japanese yen soars to fresh 18-month high against the dollar

  2. Yen Hits Fresh 18-Month High Vs Dollar

    Yen Hits Fresh 18-Month High Vs Dollar

  3. Retinal Vein Occlusion Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Bayer, Pfizer, Novartis - Research and Markets

    Retinal Vein Occlusion Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Bayer, Pfizer, Novartis - Research and Markets

  4. Open-Angle Glaucoma Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Novartis, Allergan, Pfizer - Research and Markets

    Open-Angle Glaucoma Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Novartis, Allergan, Pfizer - Research and Markets

  5. Rosacea Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Nestle, Bayer, Allergan - Research and Markets

    Rosacea Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Nestle, Bayer, Allergan - Research and Markets

  6. Ocular Hypertension Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Santen Pharma, Aerie Pharma, Valeant Pharma - Research and Markets

    Ocular Hypertension Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Santen Pharma, Aerie Pharma, Valeant Pharma - Research and Markets

  7. Fabry Disease Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Shire, Actelion - Research and Markets

    Fabry Disease Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Shire, Actelion - Research and Markets

  8. Hidradenitis Suppurativa Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, AstraZeneca, Amgen - Research and Markets

    Hidradenitis Suppurativa Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AbbVie, AstraZeneca, Amgen - Research and Markets

  9. CURRENCIES: Dollar Mixed, On Track For Weekly Gain, As Investors Await Guidance From G-20 Leaders

    CURRENCIES: Dollar Mixed, On Track For Weekly Gain, As Investors Await Guidance From G-20 Leaders

  10. UPDATE: Dollar mixed, on track for weekly gain, as investors await guidance from G-20 leaders

    UPDATE: Dollar mixed, on track for weekly gain, as investors await guidance from G-20 leaders

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.